NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02492711,Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer,https://clinicaltrials.gov/study/NCT02492711,SOPHIA,COMPLETED,"The purpose of this study is to determine whether patients with metastatic breast cancer treated with margetuximab plus chemotherapy have longer progression free survival (PFS) and overall survival (OS) than patients treated with trastuzumab plus chemotherapy.

A non-randomized sub-study cohort of approximately 88 patients will be enrolled to evaluate the safety of a reduced margetuximab infusion rate in patients receiving margetuximab either as monotherapy or in combination with chemotherapy.",YES,HER-2 Positive Breast Cancer|Metastatic Neoplasm,BIOLOGICAL: Margetuximab|BIOLOGICAL: Trastuzumab|DRUG: Physician's choice of chemotherapy.,"Progression-free Survival (PFS) as Determined by Independent Radiological Review., PFS is measured from the time of randomization until first documented disease progression or death from any cause, whichever is first., Tumor assessments are conducted every 6 weeks for the first 24 weeks and then every 24 weeks until progression of cancer, average 5 months.|Overall Survival (OS) Defined as the Number of Days From Randomization to the Date of Death (From Any Cause)., Overall survival is the time from randomization until death from any cause, Throughout the study, average 21 months|Number of Patients With Grade 3 or Higher Infusion Related Reactions, Incidence of Grade 3 or higher infusion-related reactions for patients receiving 60-minute or 30-minute infusions of margetuximab in Cycle 2 of treatment, 22 days","To Evaluate Progression-free Survival (PFS), as Assessed by Study Investigators., Tumor assessments are conducted every 6 weeks for the first 24 weeks and then every 24 weeks until progression of cancer, up to 6.5 years.|To Evaluate the Objective Response Rate (ORR) as Determined by Independent Radiological Review., Objective response rate includes all patients with either a complete response (CR) or a partial response (PR) to study treatment, Tumor assessments are conducted every 6 weeks for the first 24 weeks and then every 24 weeks until progression of cancer, up to 6.5 years.|Infusion Rate Sub-study All Safety, Incidence of all grades of infusion-related reactions, Throughout the study, average duration 6 months",,MacroGenics,,ALL,"ADULT, OLDER_ADULT",PHASE3,624,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CP-MGAH22-04,2015-08-24,2021-08-11,2022-06-14,2015-07-09,2022-11-23,2025-03-25,"Ironwood Cancer & Research Center, Chandler, Arizona, 85224, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Western Regional Medical Center, Inc., Goodyear, Arizona, 85338, United States|East Valley Hematology And Oncology, Burbank, California, 91505, United States|UCLA Hematology Oncology Santa Monica, Los Angeles, California, 90095, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Sharp Memorial Hospital, San Diego, California, 92123, United States|University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115, United States|Kaiser Permenente Medical Center, Vallejo, California, 94589, United States|Poudre Valley Health Care, Inc., Fort Collins, Colorado, 80528, United States|MedStar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Florida Cancer Specialists, Fort Myers, Florida, 33916, United States|Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States|Florida Cancer Specialists, New Port Richey, Florida, 34655, United States|Orlndo Health Cancer Center, Orlando, Florida, 32806, United States|Hem-Onc Associates, Port Saint Lucie, Florida, 34952, United States|Palm Beach Cancer Center, West Palm Beach, Florida, 33401, United States|Piedmont Cancer Institute, P.C., Atlanta, Georgia, 30318, United States|Northwest Georgia Oncology Centers, PC, Marietta, Georgia, 30060, United States|CTCA - Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, 96819, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|CTCA - Midwestern Regional Medical Center, Zion, Illinois, 60099, United States|Indiana University Health Goshen Center for Cancer Care, Goshen, Indiana, 46526, United States|ARH Cancer Clinic, Hazard, Kentucky, 41701, United States|St. Joseph's Hospital, Lexington, Kentucky, 40504, United States|Touro Infirmary Hospital, New Orleans, Louisiana, 70115, United States|New England Cancer Specialists, Scarborough, Maine, 04074, United States|Mercy Medical Center, Baltimore, Maryland, 21202, United States|Tufts-NEMC Cancer Center, Boston, Massachusetts, 02111, United States|Forrest General Hospital, Hattiesburg, Mississippi, 39401, United States|Saint Luke's Cancer Specialists, Kansas City, Missouri, 64111, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, 63141, United States|Dartmouth-Hitchcock - Norris C, Lebanon, New Hampshire, 03756, United States|New Jersey Hematology Oncology Associates, Brick, New Jersey, 08724, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Saint Barnabas Medical Center - The Cancer Center, Livingston, New Jersey, 07039, United States|New Mexico Cancer Care Alliance (NMCCA), Albuquerque, New Mexico, 87106, United States|Queens Hospital Center, Jamaica, New York, 11432, United States|ProHEALTH CARE Associates, LLP, Lake Success, New York, 11042, United States|New York University Clinical Cancer Center, New York, New York, 10016, United States|Wake Forest University Baptist Medical Center (WFUBMC), Winston-Salem, North Carolina, 27157, United States|Mercy Physicians Of Oklahoma, Oklahoma City, Oklahoma, 73120, United States|Pinnacle Health Cancer Institute, Harrisburg, Pennsylvania, 17109, United States|Monongahela Valley Hospital, Monongahela, Pennsylvania, 15063, United States|CTCA - Eastern Regional Medical Center, Inc., Philadelphia, Pennsylvania, 19124, United States|Guthrie Medical Group, PC, Sayre, Pennsylvania, 18840, United States|Tennessee Oncology, PLLC, Chattanooga, Tennessee, 37404, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Austin Cancer Center, Austin, Texas, 78758, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, 76104, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22908, United States|Inova Schar Cancer Institute, Fairfax, Virginia, 22031, United States|Fort Belvoir Community Hospital, Fort Belvoir, Virginia, 22060, United States|Swedish Cancer Institute/ Swedish Health Services, Seattle, Washington, 98104, United States|University of Washington/ Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Cancer Care Northwest, PS, Spokane, Washington, 99202, United States|Medizinische Universität Innsbruck, Innsbruck, Tirol, 6020, Austria|UZ Antwerpen, Edegem, Antwerpen, 2650, Belgium|GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk, Antwerpen, 2610, Belgium|Clinique Saint-Pierre Ottignies, Ottignies, Brabant Wallon, 1340, Belgium|UZ Brussel - Campus Jette, Brussels, Brussels Capital Region, 1090, Belgium|Cliniques universitaires Saint-Luc, Brussels, Brussels Capital Region, 1200, Belgium|Jessa Ziekenhuis - Campus Virga Jesse, Hasselt, Limburg, 3500, Belgium|AZ Nikolaas - Campus Sint-Niklaas Moerland, Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium|AZ Sint-Jan Brugge - Oostende - Campus Sint-Jan, Brugge, West-Vlaanderen, 8000, Belgium|AZ Groeninge - Campus Loofstraat, Kortrijk, West-Vlaanderen, 8500, Belgium|AZ Damiaan, Oostende, West-Vlaanderen, 8400, Belgium|Chc - Clinique Saint-Joseph, Liège, 4000, Belgium|Clinique Sainte Elisabeth, Namur, 5000, Belgium|Dr. Leon Richard Oncology Centre, Moncton, New Brunswick, E1C 8X3, Canada|Lakeridge Health Oshawa, Oshawa, Ontario, L1G 2B9, Canada|Masarykuv onkologicky ustav, Brno, Brno-město, 656 53, Czechia|Fakultni nemocnice Olomouc, Olomouc, 779 00, Czechia|Fakultni nemocnice v Motole, Praha 5, 150 06, Czechia|Aarhus Universitetshospital, Aarhus C, Central Jutland, 8000, Denmark|Regionshospitalet Herning (Herning Centralsygehus), Herning, Central Jutland, 7400, Denmark|Vejle Sygehus, Vejle, South Denmark, 7100, Denmark|Næstved Sygehus, Aarhus N, Zeeland, 4700, Denmark|Tampere University Hospital, Tampere, Etelä-Suomen Lääni, 33521, Finland|Helsinki University Central Hospital (HUCH) - Meilahden Sair, Helsinki, Länsi-Suomen Lääni, 00029, Finland|Center de Lutte Contre le Cancer (CLCC), Nice, Alpes-Martitimes, 06189, France|Center de Lutte Contre le Cancer (CLCC), Caen cedex 05, Calvados, 14076, France|Centre Georges-François Lecler, Dijon, Côte-d'Or, 21079, France|Centre de Lutte Contre le Cancer (CLCC) - Institut de Cancer, St Herblain, Loire-Atlantique, 44805, France|Centre Jean Perrin, Clermont-Ferrand, Puy-de-Dôme, 63011, France|Centre Léon Bérard, Lyon Cedex 08, Rhône-Alpes, 69373, France|Institut Curie, Paris, Île-de-France, 75005, France|Institut Curie - Hôpital René Huguenin, Saint-Cloud, Île-de-France, 92210, France|Universitaetsklinikum Tuebingen, Tuebingen, Baden-Württemberg, 72076, Germany|Universitätsklinikum Erlangen, Erlangen, Bayern, 91054, Germany|Praxis für Frauenheilkunde Anita, München, Bayern, 81925, Germany|Marien Hospital Düsseldorf, Düsseldorf, Nordhein-Westfalen, 40479, Germany|Universitaetsklinikum Essen - Klinik fuer Frauenheilkunde, Essen, Nordrhein-Westfalen, 45122, Germany|Marien Hospital, Witten, Nordrhein-Westfalen, 58452, Germany|Medizinische Fakultät Carl Gustav Carus, Dresden, Sachsen, 01307, Germany|Universtatsklinikum Heidelberg Nationales, Heidelberg, Germany|Soroka Medical Center [Oncology], Beersheba, HaDarom, 84802, Israel|Meir Medical Center, Kfar Saba, HaMerkaz, 44281, Israel|Rabin Medical Center - Beilinson Hospital, Petaẖ Tiqwa, HaMerkaz, 49100, Israel|The Chaim Sheba Medical Center - Insititute of Oncology, Ramat Gan, HaMerkaz, 52621, Israel|Kaplan Medical Center, Rehovot, HaMerkaz, 761001, Israel|Hadassah Medical Organisation, Hadassah Medical Center, Ein-Karem, Jerusalem, Yerushalayim, 91120, Israel|Clalit Health Services - Lin Medical Center, Haifa, 35152, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel|PO Garibaldi-Nesima, ARNAS Garibaldi, Catania, Cantania, 95122, Italy|Irccs Irst, Meldola, Forli, 47014, Italy|Istituto di Candiolo, IRCCS, Candiolo, Torino, 10060, Italy|Azienda Ospedaliero Universitaria Senese Universita degli St, Siena, Toscana, 53100, Italy|Ospedale Umberto I, AOU Ospedali Riuniti Umberto I - GM.Lanc, Ancona, 60126, Italy|AO G.Rummo, Benevento, 82100, Italy|ASST Papa Giovanni XXIII - Oncologia-Bergamo, Bergamo, 24127, Italy|PO di Cremona, ASST di Cremona - Patologia Mammaria e Breast Unit - Cremona, Cremona, 26100, Italy|Arcispedale S.Anna, AOU di Ferrara, Ferrara, 44124, Italy|E.O. Ospedali Galliera, Genova, 16128, Italy|PO A.Manzoni di Lecco, ASST Lecco - Oncologia Medica - Lecco, Lecco, 23900, Italy|Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano, 20121, Italy|Istituto Europeo di Oncologia Via Ripamonti, Milano, 20141, Italy|AOU Policlinico di Modena, Modena, 41122, Italy|Fondazione Pascale, IRCCS Istituto Nazionale dei Tumori, Napoli, 80131, Italy|AOU di Parma, Parma, 43126, Italy|IRCCS Policlinico San Matteo, Pavia, 27100, Italy|IRCSS Fodazione Salvatore Maugeri, Pavia, 27100, Italy|SO S.Chiara, AOU Pisana, Pisa, 56126, Italy|Nuovo ospedale di Prato, Prato, 59100, Italy|PU Campus Bio-medico di Roma, Roma, 00128, Italy|AO S.Andrea, Università degli Studi di Roma La Sapienza, Roma, 00189, Italy|Ospedale Belcolle Viterbo, Viterbo, 01100, Italy|Seoul National University Hospital, Seoul, Seoul Teugbyeolsi, 03080, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seoul Teugbyeolsi, 03722, Korea, Republic of|Asan Medical Center, Seoul, Seoul Teugbyeolsi, 05505, Korea, Republic of|Samsung Medical Center, Seoul, Seoul Teugbyeolsi, 06351, Korea, Republic of|Maastricht University Medical Centre, Maastricht, Limburg, 6229 HX, Netherlands|Haga Ziekenhuis, loc. Leyenburg, Haag, Zuid-Holland, 2545 CH, Netherlands|MAGODENT Sp. z o.o., Warszawa, Mazowieckie, 04-125, Poland|Mazowiecki Szpital Onkologiczny, Wieliszew, Mazowieckie, 05-135, Poland|Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Lublin, 20-090, Poland|Centro Clínico Champalimaud/Fundação Champalimaud, Lisbon, Lisboa, 1400-038, Portugal|H. Santa Maria - Centro Hospitalar Lisboa Norte, Lisboa, 1649-035, Portugal|Instituto Português Oncologia Francisco Gentil do Porto, Porto, 4200-072, Portugal|Fundacion de Investigacion de Diego, San Juan, 927, Puerto Rico|H.U.V. del Rocío, Sevilla, Andalucía, 41013, Spain|Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Universitari Parc Taulí, Sabadell, Barcelona, 08208, Spain|Hospital del Mar, Barcelona, Catalunya, 08003, Spain|H.C.U. Valencia, Valencia, Comunidad, 46010, Spain|Hospital de Navarra, Pamplona, Navarra, 31008, Spain|H.U. Sant Joan de Reus, Reus, Tarragona, 43204, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08023, Spain|H. San Pedro de Alcántara, Cáceres, 10003, Spain|H.U. Arnau de Vilanova, Lleida, 25198, Spain|M.D. Anderson Cancer Center Madrid, Madrid, 28033, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario Clínico San Carlos, Madrid, 28040, Spain|Fundación Instituto Valenciano de Oncología, Valencia, 46009, Spain|Hospital Universitari I Politecnic La Fe, Valencia, 46026, Spain|Hospital Ntra. Sra. de Sonsoles, Ávila, 5004, Spain|Guys and St Thomas Hospital, London, City Of London, SE1 9RT, United Kingdom|Castle Hill Hospital (Hull), Hull, East Riding Of Yorkshire, HU16 5JQ, United Kingdom|Kent Oncology Centre, Maidstone Hospital, Maidstone, Kent, ME16 9QQ, United Kingdom|Royal Preston Hospital, Fulwood, Lancashire, PR2 9HT, United Kingdom|South Tees Hospitals NHS Foundation Trust, Middlesbrough, TS4 3BW, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/11/NCT02492711/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/11/NCT02492711/SAP_001.pdf"
